ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
What I'd buy first if the ASX share market fell 30%
Broker Notes
These ASX 200 shares could rise 25% to 30%
How to invest
How to make $50,000 of passive income a year from ASX shares
How to invest
My plan of attack for the next share market crash
Growth Shares
2 screaming buy ASX shares I'd hold for the next 20 years
Share Gainers
Here are the top 10 ASX 200 shares today
Growth Shares
3 amazing ASX growth shares to buy and hold until 2035
Share Market News
5 top ASX ETFs to buy and hold for 5 years+
Growth Shares
3 proven ASX compounders that could double your money over time
How to invest
How to make your first $10,000 in the ASX share market
Healthcare Shares
Why this leading fundie is tipping ResMed shares for near-term gains
Growth Shares
The best ASX growth shares to buy with $3,000 this month
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.